×
Newsmax TV & Webwww.newsmax.comFREE - In Google Play
VIEW
×
Newsmax TV & Webwww.newsmax.comFREE - On the App Store
VIEW
Tags: epilepsy | Aptiom | eslicarbazepine | seizures | drug

FDA OKs New Epilepsy Drug

Saturday, 09 November 2013 09:39 AM

U.S. health regulators on Friday approved a new drug made by Sunovion Pharmaceuticals, a U.S.-based unit of Japanese drugmaker Dainippon Sumitomo Pharma Co, as an add-on medicine to reduce seizures associated with epilepsy.

The drug, to be sold under the brand name Aptiom and known chemically as eslicarbazepine, significantly reduced the frequency of epileptic seizures compared with a placebo in clinical trials.

"Some patients with epilepsy do not achieve satisfactory seizure control from existing treatments," Eric Bastings, acting director of the FDA's Division of Neurology Products, said in a statement. "It is important we continue to make new treatment options available to patients.
 
Like other antiepileptic drugs, Aptiom may cause suicidal thoughts or actions in a very small number of people, the Food and Drug Administration cautioned in its approval announcement.

© 2021 Thomson/Reuters. All rights reserved.


Health-News
U.S. health regulators on Friday approved a new drug made by Sunovion Pharmaceuticals,a U.S.-based unit of Japanese drugmaker Dainippon Sumitomo Pharma Co,as an add-on medicine to reduce seizures associated with epilepsy.The drug, to be sold under the brand name Aptiom and...
epilepsy,Aptiom,eslicarbazepine,seizures,drug
131
2013-39-09
Saturday, 09 November 2013 09:39 AM
Newsmax Media, Inc.
More Articles
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved